Novo Nordisk A/S (NVO)
39.05
-0.38
(-0.96%)
USD |
NYSE |
Oct 23, 16:00
39.01
-0.04
(-0.10%)
Pre-Market: 20:00
Novo Nordisk Price : 39.05 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 39.21 | 39.29 | 38.75 | 39.05 | 9.188M |
| Oct 22, 2026 | 39.39 | 39.76 | 39.24 | 39.43 | 8.561M |
| Oct 21, 2026 | 39.25 | 39.49 | 39.05 | 39.06 | 6.803M |
| Oct 20, 2026 | 38.92 | 39.38 | 38.81 | 39.35 | 9.413M |
| Oct 19, 2026 | 38.65 | 38.84 | 38.35 | 38.42 | 7.453M |
| Oct 16, 2026 | 39.33 | 39.40 | 38.67 | 38.83 | 10.82M |
| Oct 15, 2026 | 38.99 | 39.68 | 38.89 | 39.22 | 14.78M |
| Oct 14, 2026 | 37.90 | 38.42 | 37.90 | 38.12 | 9.364M |
| Oct 13, 2026 | 38.74 | 38.89 | 37.98 | 38.06 | 9.262M |
| Oct 12, 2026 | 38.85 | 38.85 | 38.26 | 38.58 | 8.722M |
| Oct 09, 2026 | 38.11 | 38.68 | 38.06 | 38.64 | 9.645M |
| Oct 08, 2026 | 37.80 | 38.23 | 37.50 | 38.18 | 11.82M |
| Oct 07, 2026 | 37.57 | 38.47 | 37.51 | 38.26 | 13.67M |
| Oct 06, 2026 | 37.35 | 37.53 | 36.84 | 37.53 | 13.70M |
| Oct 05, 2026 | 36.94 | 37.61 | 36.86 | 37.54 | 18.70M |
| Oct 02, 2026 | 37.64 | 37.65 | 37.17 | 37.32 | 10.26M |
| Oct 01, 2026 | 37.80 | 37.97 | 37.36 | 37.40 | 12.66M |
| Sep 30, 2026 | 38.05 | 38.77 | 37.88 | 37.91 | 21.56M |
| Sep 29, 2026 | 38.21 | 38.38 | 38.05 | 38.31 | 9.404M |
| Sep 28, 2026 | 38.40 | 38.90 | 38.23 | 38.71 | 11.43M |
| Sep 25, 2026 | 38.81 | 38.83 | 38.41 | 38.80 | 10.06M |
| Sep 24, 2026 | 37.95 | 38.72 | 37.92 | 38.62 | 20.06M |
| Sep 23, 2026 | 38.90 | 39.14 | 38.16 | 38.17 | 18.44M |
| Sep 22, 2026 | 39.50 | 39.89 | 39.10 | 39.40 | 24.46M |
| Sep 21, 2026 | 41.05 | 41.17 | 39.54 | 39.80 | 49.34M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AstraZeneca PLC | 171.49 |
| GSK Plc | 50.75 |
| Johnson & Johnson | 263.81 |
| Eli Lilly & Co. | 1273.46 |
| Merck & Co., Inc. | 145.27 |
Price Related Metrics
| PE Ratio | 9.544 |
| PS Ratio | 3.374 |
| PEG Ratio | 0.7574 |
| Price to Book Value | 5.101 |
| Price to Free Cash Flow | 23.09 |
| Earnings Yield | 10.48% |
| Market Cap | 130.66B |
| PEGY Ratio | 0.5549 |
| Operating PE Ratio | 7.436 |
| Normalized PE Ratio | 9.174 |